CClinicalTrials.gg
CompletedNCT05537363Updated Aug 31, 2026

Agility Training and Its Relations in Elderly Adults With and Without MCI

An interventional study of Health education and Multicomponent training in Elderly Adults, Mild Cognitive Impairment and Healthy, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
83
Allocation
Randomized
Ages
20 Years to 100 Years
Sex
All
01

Study summary

The following three-part proposal will focus on the effects of agility training as well as the relationship between agility ability and motor and cognitive function, and risk of falls in elderly adults with or without mild cognitive impairment (MCI).

Part I is a cross-sectional study design that will assess the level of agility in healthy young adults, healthy elderly adults, and elderly adults with MCI to determine the effect of aging and cognition decline on agility and the relations between agility, cognitive, and motor functions. Thirty participants will be screened for eligibility and recruited for each group (90 participants total). After collecting basic data, all participants will undergo cognitive and motor function tests, as well as an agility test. Cognitive function tests include tests of global cognition, working memory, mental set shifting, and selective attention. Motor function tests include tests of single and dual task walking, strength, power, balance, flexibility, and endurance. The agility test contains stop-and-go, change of direction, and spatial orientation components. Functional near-infrared spectroscopy (fNIRS) will be used to evaluate the brain activation during the agility test, cognitive tests, and single and dual task walking. Results from all tests will be used to determine the motor, cognitive, and other predictive factors associated with agility performance, and will be used in the design of the training program in Part II and III.

Part II and III are single-blinded randomized controlled trials that will explore the short and long-term effects of a multicomponent training and an agility training protocol on agility, motor, and cognitive function in elderly adults with and without MCI. Seventy-five elderly adults with MCI (Part II) and seventy-five healthy elderly (Part III) will be recruited. After screening for eligibility and collection of demographic data, participants will undergo a pretest assessment. In addition to the motor, cognitive, and agility tests used in Part I, information on history of falls, falls efficacy, and quality of life will be assessed for each participant. Brain activation will be assessed during the agility test, cognitive tests, and single and dual task walking assessments using fNIRS. Participants will be randomly allocated into one of three groups: the control group, the multicomponent training group, or the agility training group (n=25 in each group). Intervention will be executed at a frequency of 45 minutes per session, 2 times a week for 8 weeks. The control group will receive home-based health education guidelines. The multicomponent training group will engage in 3 to 4 exercises each training session comprising the influencing factors of agility, and the agility training group will engage in integrated task-specific training. A post-test will be conducted after the 8-week intervention, and 1-month, 6-month, and 12-month follow-ups will be conducted for elderly adults with MCI. The healthy elderly adults will be assessed after the intervention and at the 1-month follow-up after training.

02

Conditions studied

  • Elderly Adults
  • Mild Cognitive Impairment
  • Healthy

Keywords

  • Aging
  • Agility training
  • Cognition function
  • Fall
  • Mild Cognitive Impairment
  • Motor function
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 83 is above the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Part 1:

Inclusion Criteria:

  1. has a score of ≥ 24 on the Mini-Mental State Examination (MMSE)
  2. able to walk independently for more than 30 meters without assistive aids
  3. able to follow orders

Exclusion Criteria:

  1. poorly-controlled or unstable systematic disease
  2. has a history of central nervous system disease
  3. currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
  4. subjects with achromatopsia

Part 2:

Inclusion Criteria:

  1. older than 65 years old
  2. score of Mini-Mental State Examination (MMSE) ≥ 24 and score of Montreal Cognitive Assessment (MoCA) ≤ 26
  3. able to walk independently for more than 30 meters without assistive aids
  4. able to follow orders

Exclusion Criteria:

  1. poorly controlled or unstable systematic disease
  2. has a history of central nervous system disease
  3. currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
  4. has other medical conditions for which exercise is contraindicated
  5. subjects with achromatopsia

Part 3:

Inclusion Criteria:

  1. older than 65 years old
  2. score of Mini-Mental State Examination (MMSE) ≥ 24
  3. able to walk independently for more than 30 meters without assistive aids
  4. able to follow orders

Exclusion Criteria:

  1. poorly controlled or unstable systematic disease
  2. has a history of central nervous system disease
  3. currently taking antidepressants, anti-anxiety, or other psychiatric drugs that may affect blood flow in the brain
  4. has other medical conditions for which exercise is contraindicated
  5. subjects with achromatopsia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
83 participants (actual)

Study arms

  • No intervention
    Healthy adults

    Year 1: To assess levels of agility and agility performance in relation to the motor and cognitive abilities of healthy young adults, healthy elderly, and elderly with MCI.

  • No intervention
    Healthy elderly and mild cognitive impairment elderly

    Year 1: To assess levels of agility and agility performance in relation to the motor and cognitive abilities of healthy young adults, healthy elderly, and elderly with MCI.

  • Active comparator
    Mild cognitive impairment elderly with health education

    Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.

    Other: Health education

  • Experimental
    Mild cognitive impairment elderly with multicomponent training

    Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.

    Other: Multicomponent training

  • Experimental
    Mild cognitive impairment elderly with agility training

    Year 2: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility, motor, and cognitive function in elderly with MCI.

    Other: Agility training

  • Active comparator
    Healthy elderly with health education

    Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.

    Other: Health education

  • Experimental
    Healthy elderly with multicomponent training

    Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.

    Other: Multicomponent training

  • Experimental
    Healthy elderly with agility training

    Year 3: To determine the short and long-term effects of a multicomponent training protocol and an agility training protocol on agility ability, motor, and cognitive function in healthy elderly adults.

    Other: Agility training

Interventions

  • OtherHealth education

    Participants in the control group will receive health educational guidelines. Guideline contents include home-based exercise program, nutrition recommendations, and fall prevention education.

  • OtherMulticomponent training

    Multicomponent exercises will be designed according to the results of Part I of our study. Results of Part I of this study will determine the contributing factors of agility, such as muscle strength, endurance, and cognitive function. A physical therapist will train the participants 3-4 exercises (3-4 factors) in each session. The physical therapist will adjust the difficulty of each exercise according to the participant's ability and condition.

  • OtherAgility training

    The agility-based task-specific exercises will be conducted in this group and will incorporate stop-and-go, change in direction, change in velocity, acceleration and deceleration training. There are four training configurations with 3 levels of difficulty, which will be manipulated by increasing speed, distance, number of repetitions, number of directions, congruency, and/or complexity of the task, or by decreasing the number and duration of the rest intervals. The physical therapist will adjust the difficulty of each exercise according to the participant's ability and condition.

06

What researchers measure

Primary outcomes

  1. Agility Challenge for the Elderly (ACE)

    An agility course developed for a 9m x 18m volleyball court and includes three segments that each aim to test a specific aspect of agility, including stop-and-go, change of direction, and spatial orientation.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

Secondary outcomes

  1. Fall history and fear of falls

    Fall history will be recorded by the number of fall episodes in the past 6 months and whether it caused injury.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  2. Quality of life (QOL)

    Quality of life (QOL) will be evaluated by Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36).

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  3. Brain activation

    A multichannel wearable fNIRS imaging system (NIRSport2, NIRx Medical Technologies LLC, Glen Head, NY, USA) will be used to detect the hemodynamics of brain areas associated with the agility test, cognitive tasks, and single and dual task walking test.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  4. Montreal Cognitive Assessment (MoCA)

    MoCA contains 16 items and 11 categories to assess multiple cognitive domains, is a screening instrument for MCI, and its validity has been established in various clinical groups and countries.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  5. Mental set shifting

    The Wisconsin Card Sorting Test (WCST) will be used to measure participants' ability to shift their cognitive ability in response to the demands of environment.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  6. Working memory

    The backward digit span test (DGS) will be used to measure working memory.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  7. Selective attention and inhibition

    The Stroop Color and Word Test (SCWT) will be used to measure selective attention.

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

  8. Motor Function

    Walking performance, normal walking, cognitive dual-task walking, muscle strength of bilateral lower limbs, five times sit to stand test, timed up and go, quiet static standing task, and the 360° turning task, flexibility, 6-minute walk test (6WMT).

    Time frame: Part 1:Baseline; Part 2: Pre-intervention, 8 weeks, 12 weeks, 8-month, and 14-month

07

Study locations

1 site
  • National Taiwan University
    Taipei, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05537363
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Sep 13, 2022
Start date
Sep 28, 2022
Primary completion
Mar 13, 2025
Completion
Mar 13, 2025
Last update
Aug 31, 2026

Study contacts

Yan Ci Liu, PhD
principal investigator · National Taiwan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion